Granules India Ltd. (India)

Granules India Limited is a non-government company located in Hyderabad, India. It was incorporated on March 18, 1991, and is registered at the Registrar of Companies in Hyderabad. The company's main focus is on the manufacture of basic chemicals. Its authorized share capital is Rs. 505,000,000, and its paid-up capital is Rs. 248,292,756. The company's Annual General Meeting (AGM) date is not available, and its balance sheet was last filed on March 31, 2022, according to records from the Ministry of Corporate Affairs (MCA). The directors of Granules India Limited include Krishna Prasad Chigurupati, Umadevi Chigurupati, Arun Rao Akinepally, Kapil Mehan, Harsha Chigurupati, Arun Sawhney, Basava Sankar Rao Kolli, Saumen Chakraborty, Palepu Sucharita Rao, and Kandiraju Venkata Sitaramrao. Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in various markets, including India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs cover a range of therapeutic categories, including anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles, as well as other products for oncology. Granules India Limited also exports its products. The company's Corporate Identification Number is L24110TG1991PLC012471, and its registration number is 12471. The registered address of Granules India Limited is located at Second Floor, Block III, My Home Hub Madhapur, Cyberabad, Hyderabad, TG 500081, India. The company's current status is active.